The downregulation of Epidermal Growth Factor Receptor (EGFR) and Proline, Glutamic Acid, and Leucine Rich Protein 1 (PELP1) can reduce hormone resistance in breast cancer cells to therapy. Here, EGFR is linked to breast carcinoma.